|
Funding from major opioid settlements is helping communities across Minnesota combat the opioid crisis. A new tool shows just where the funding is going, and how communities are using funds.
Counties and cities must report yearly on expenditures funded with opioid settlement funds. The Minnesota Department of Human Services collects this data and reports it every year by Aug. 1.
The first year of this reporting has been completed and published, with viewable data now available on the Opioid Epidemic Response Spending webpage.
Cities and counties began receiving their shares of settlement dollars in fall 2022. During calendar year 2022, counties and cities spent a total of $515,253 on supporting programs, staffing and administrative needs to address the opioid epidemic in Minnesota.
Background
In July 2021, the Minnesota Attorney General’s Office announced settlement agreements with pharmaceutical distributors McKesson, Cardinal Health and AmerisourceBergen, and opioid manufacturer Johnson & Johnson. In December 2022, the Attorney General’s Office announced five additional settlements with major opioid manufacturers Teva Pharmaceuticals and Allergan, and three of the nation’s largest retail pharmacy chains—Walmart, CVS and Walgreens. Together, these settlements will bring more than $540 million into Minnesota over the next 18 years to fight the opioid crisis.
On Dec. 6, 2021, the Attorney General’s Office announced an agreement with Minnesota cities and counties on how funds from these settlements will be allocated: 75% to counties and cities that sign on, and 25% to the state to be spent on opioid response.
For any questions regarding settlement reporting data, please reach out to BHD_Opioid@state.mn.us. For additional details on Minnesota’s response to the opioid settlement:
|
